Received May 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (DAPTACEL) | SANOFI PASTEUR | UNK | — | — |
dose of DAPTACEL with a labeled expiration date of 4/30/2026 was administered to a patient on 5/8/2026 with no AE; Initial information received on 13-May-2026 regarding an unsolicited valid non-serious courtesy case received from other healthcare professional. This case involves a patient of unknown age and unknown gender who received an expired dose of diphtheria-15/tetanus/5 AC pertussis vaccine [Daptacel] with no adverse event. The patient's past medical history, past drugs, vaccination(s), family history, and concomitant medications were not provided. On 08-May-2026, the patient received an unknown dose of diphtheria-15/tetanus/5 AC pertussis vaccine suspension for injection (batch/lot number: unknown; expiry date: 30-Apr-2026) (strength: unknown) via unknown route in an unknown administration site for prophylactic vaccination [Immunisation] with no adverse event (expired product administered, and latency: same day). Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medication error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.